Tactile Systems Technology Inc

NASDAQ TCMD

Data sourced from

and

Download Data

Tactile Systems Technology Inc Cash Flow Coverage Ratio 3 year CAGR for the quarter ending December 31, 2023

Tactile Systems Technology Inc Cash Flow Coverage Ratio 3 year CAGR is NA for the quarter ending December 31, 2023. The cash flow coverage ratio evaluates a company's ability to cover its interest expense with its operating cash flow after deducting capital expenditures. It is calculated by dividing the difference between operating cash flow and capital expenditures by interest expense. This ratio indicates the company's ability to generate enough cash flow to service its interest payments. A higher ratio signifies better coverage and financial stability. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.

Tactile Systems Technology Inc Cash Flow Coverage Ratio for the quarter ending March 31, 2023 was -0.80, a 69.34% change year over year.
Tactile Systems Technology Inc Cash Flow Coverage Ratio for the quarter ending March 31, 2022 was -2.60.

NASDAQ: TCMD

Tactile Systems Technology Inc

CEO	Mr. Daniel L. Reuvers
IPO Date	July 28, 2016
Location	United States
Headquarters	3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416
Employees	992
Sector	Healthcare
Industry	Medical devices

Description

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Key trends